Novel approaches in the management of CML and MPN: new UK guidelines and targeted therapy
Tracks
-
| Monday, April 20, 2026 |
| 3:25 PM - 4:55 PM |
| Hall 1A, Upper Level |
Speaker
Dr. Kate Rothwell
Consultant
Leeds Teaching Hospitals NHS Trust
BSH 2026 Guideline Update
3:25 PM - 3:45 PM
Dr. Simone Claudiani
CML and MPN Clinical Specialist
Imperial College Healthcare NHS Trust
New strategies in Treatment free remission and how to stop TKI for the second time
3:50 PM - 4:10 PM
Dr. Fiona Fernando
Consultant Haematologist
Imperial College NHS Healthcare Trust
Fatigue and cognitive dysfunction on BCR::ABL inhibitors in CML
4:15 PM - 4:25 PM
Prof. Adam Mead
Professor Of Haematology
University of Oxford
Why is ruxolitinib not the imatinib for MPN?
4:30 PM - 4:50 PM
Prof. Dragana Milojkovic
Consultant Haematologist, Professor of Practice
Hammersmith Hospital, Imperial College NHS Trust, London
Session Chair
